发现氨酸结合的氨酸作为一种新型的潜在抗菌剂
Shi-Yu Huang1, Nisar Ahmad1, Xiao-Han Zhang1
1Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, PR China.
Bioorganic chemistry
|December 13, 2025
概括
研究人员开发了新型氨酸结合胺 (CCHs) 来对抗多药耐药细菌. 化合物CCH8c具有强大的多目标抗菌活性,具有较低的抗药性潜力,提供了一个有前途的新药候选者.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 多抗药性细菌的兴起需要开发具有独特作用机制的新型抗菌剂.
- 现有的抗菌药物面临着广泛耐药性的挑战,迫切需要创新的治疗策略.
- 氨酸结合胺醇 (CCHs) 是一个独特的结构类,具有多目标抗菌作用的潜力.
研究的目的:
- 合成和评估一种新型系列的氨酸结合胺 (CCHs) 对它们对抗多药耐药病原体的抗菌活性.
- 识别和描述CCH系列中的特定化合物,这些化合物具有强大且广泛的抗菌疗效.
- 阐明作用机制并评估有前途的CCH候选者的安全概况.
主要方法:
- 一个库的合成库玛林结合酸英多尔 (CCHs).
- 对抗细菌菌株的最小抑制度 (MIC) 的确定,包括金黄色葡萄球菌 (Staphylococcus aureus) ATCC 25923.
- 评估生物安全性,杀菌活性动力学和耐药性倾向.
- 研究包括膜完整性,DNA间隔,活性氧物种生成和酶抑制 (乳酸脱酶) 在内的机制.
- 分子对接研究,以预测与目标酶的结合相互作用.
主要成果:
- 基乙CCH 8c表现出强大的抗菌活性,其低MIC为1μg/mL,对黄金葡萄球菌 (Staphylococcus aureus) ATCC 25923.
- CCH 8c表现出有利的生物安全性,快速的杀菌作用,以及较低的耐药性发展倾向.
- 该化合物通过多个点起作用:破坏膜完整性,抑制DNA复制,诱导活性氧物种和抑制乳酸脱酶.
- 分子对接表明,CCH8c通过非共价相互作用与乳酸脱酶结合,抑制其酶功能.
结论:
- CCH 8c是一种有前途的多向抗菌剂,对抗多药耐药细菌具有显著的潜力.
- CCH 8c的多目标机制有助于其低电阻的发展.
- 为了使其成为新型治疗候选药物,需要进一步探索CCH 8c.
相关概念视频
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.6K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.6K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Antimicrobial Effectiveness
879
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
879
Amines to Sulfonamides: The Hinsberg Test
4.3K
The Hinsberg test is a method to identify primary, secondary and tertiary amines, named after its pioneer, Oscar Hinsberg. Here, amines are treated with benzenesulfonyl chloride, also known as the Hinsberg reagent, in the presence of an excess of aqueous base, followed by acidification. Based on the nature of the amines, different changes are observed.
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
4.3K
Antibiotic Selection
59.3K
Overview
59.3K


